A new study is assessing patients with metastasized bowel cancer to determine whether it is possible to characterize tumor and better control resistance mechanisms with a blood test. The aim of this is to spare patients the stress of having tissue removed via biopsies and to make the targeted use of therapy easier.
http://ift.tt/1BUDj4j
http://ift.tt/1BUDj4j
No comments:
Post a Comment